275 related articles for article (PubMed ID: 26845280)
1. Selective serotonin reuptake inhibitors and congenital heart anomalies: comparative cohort studies of women treated before and during pregnancy and their children.
Petersen I; Evans SJ; Gilbert R; Marston L; Nazareth I
J Clin Psychiatry; 2016 Jan; 77(1):e36-42. PubMed ID: 26845280
[TBL] [Abstract][Full Text] [Related]
2. Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: a European register-based study.
Wemakor A; Casson K; Garne E; Bakker M; Addor MC; Arriola L; Gatt M; Khoshnood B; Klungsoyr K; Nelen V; O'Mahoney M; Pierini A; Rissmann A; Tucker D; Boyle B; de Jong-van den Berg L; Dolk H
Eur J Epidemiol; 2015 Nov; 30(11):1187-98. PubMed ID: 26148560
[TBL] [Abstract][Full Text] [Related]
3. Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark.
Jordan S; Morris JK; Davies GI; Tucker D; Thayer DS; Luteijn JM; Morgan M; Garne E; Hansen AV; Klungsøyr K; Engeland A; Boyle B; Dolk H
PLoS One; 2016; 11(12):e0165122. PubMed ID: 27906972
[TBL] [Abstract][Full Text] [Related]
4. Use of selective serotonin reuptake inhibitors in pregnancy and cardiac malformations: a propensity-score matched cohort in CPRD.
Margulis AV; Abou-Ali A; Strazzeri MM; Ding Y; Kuyateh F; Frimpong EY; Levenson MS; Hammad TA
Pharmacoepidemiol Drug Saf; 2013 Sep; 22(9):942-51. PubMed ID: 23733623
[TBL] [Abstract][Full Text] [Related]
5. Selective Serotonin Reuptake Inhibitors (SSRIs) and the Risk of Congenital Heart Defects: A Meta-Analysis of Prospective Cohort Studies.
Wang S; Yang L; Wang L; Gao L; Xu B; Xiong Y
J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25991012
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant use during early pregnancy and the risk of congenital anomalies.
Vasilakis-Scaramozza C; Aschengrau A; Cabral H; Jick SS
Pharmacotherapy; 2013 Jul; 33(7):693-700. PubMed ID: 23744675
[TBL] [Abstract][Full Text] [Related]
7. A Systematic Review and Meta-Analysis Considering the Risk for Congenital Heart Defects of Antidepressant Classes and Individual Antidepressants.
De Vries C; Gadzhanova S; Sykes MJ; Ward M; Roughead E
Drug Saf; 2021 Mar; 44(3):291-312. PubMed ID: 33354752
[TBL] [Abstract][Full Text] [Related]
8. Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births.
Gao SY; Wu QJ; Sun C; Zhang TN; Shen ZQ; Liu CX; Gong TT; Xu X; Ji C; Huang DH; Chang Q; Zhao YH
BMC Med; 2018 Nov; 16(1):205. PubMed ID: 30415641
[TBL] [Abstract][Full Text] [Related]
9. Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects.
Anderson KN; Lind JN; Simeone RM; Bobo WV; Mitchell AA; Riehle-Colarusso T; Polen KN; Reefhuis J
JAMA Psychiatry; 2020 Dec; 77(12):1246-1255. PubMed ID: 32777011
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
[TBL] [Abstract][Full Text] [Related]
11. Selective serotonin reuptake inhibitors and risk for major congenital anomalies.
Malm H; Artama M; Gissler M; Ritvanen A
Obstet Gynecol; 2011 Jul; 118(1):111-120. PubMed ID: 21646927
[TBL] [Abstract][Full Text] [Related]
12. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects.
Louik C; Lin AE; Werler MM; Hernández-Díaz S; Mitchell AA
N Engl J Med; 2007 Jun; 356(26):2675-83. PubMed ID: 17596601
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort.
Bérard A; Zhao JP; Sheehy O
BMJ Open; 2017 Jan; 7(1):e013372. PubMed ID: 28082367
[TBL] [Abstract][Full Text] [Related]
14. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects.
Alwan S; Reefhuis J; Rasmussen SA; Olney RS; Friedman JM;
N Engl J Med; 2007 Jun; 356(26):2684-92. PubMed ID: 17596602
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of severe congenital heart defects in offspring exposed to selective serotonin-reuptake inhibitors in early pregnancy--an epidemiological study using validated EUROCAT data.
Knudsen TM; Hansen AV; Garne E; Andersen AM
BMC Pregnancy Childbirth; 2014 Sep; 14():333. PubMed ID: 25258023
[TBL] [Abstract][Full Text] [Related]
16. SSRI antidepressants and birth defects.
Prescrire Int; 2006 Dec; 15(86):222-3. PubMed ID: 17167929
[TBL] [Abstract][Full Text] [Related]
17. Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study.
Ban L; Gibson JE; West J; Fiaschi L; Sokal R; Smeeth L; Doyle P; Hubbard RB; Tata LJ
BJOG; 2014 Nov; 121(12):1471-81. PubMed ID: 24612301
[TBL] [Abstract][Full Text] [Related]
18. Antidepressant use in pregnancy and the risk of cardiac defects.
Huybrechts KF; Palmsten K; Avorn J; Cohen LS; Holmes LB; Franklin JM; Mogun H; Levin R; Kowal M; Setoguchi S; Hernández-Díaz S
N Engl J Med; 2014 Jun; 370(25):2397-407. PubMed ID: 24941178
[TBL] [Abstract][Full Text] [Related]
19. Selective serotonin reuptake inhibitor or serotonin-norepinephrine reuptake inhibitors and epidemiological characteristics associated with prenatal diagnosis of congenital heart disease.
Melov SJ; Shetty PS; Pasupathy D; Kirby A; Sholler GF; Winlaw DS; Alahakoon TI
Prenat Diagn; 2021 Jan; 41(1):35-42. PubMed ID: 33067884
[TBL] [Abstract][Full Text] [Related]
20. Systematic meta-analysis of individual selective serotonin reuptake inhibitor medications and congenital malformations.
Myles N; Newall H; Ward H; Large M
Aust N Z J Psychiatry; 2013 Nov; 47(11):1002-12. PubMed ID: 23761574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
